Varian receives FDA 510(k) for single-channel HDR brachytherapy afterloader
The FDA has cleared Varian Medical Systems Inc.'s new single-channel device for delivering High-Dose Rate (HDR) brachytherapy.
Varian's MammoSource afterloader is a computer-controlled device that delivers a high-energy radioactive source through a single catheter, into the cavity left when a tumor has been surgically removed. It works with Varian's BrachyVision software, an image-guided HDR brachytherapy treatment planning system.
William Hyatt, vice president and general manager of Varian's Brachytherapy business, said the single-channel system is "specifically engineered for these single catheter treatments and is designed to reduce the capital cost barriers often faced by hospitals wishing to offer the new accelerated breast brachytherapy techniques."
Varian's MammoSource afterloader is a computer-controlled device that delivers a high-energy radioactive source through a single catheter, into the cavity left when a tumor has been surgically removed. It works with Varian's BrachyVision software, an image-guided HDR brachytherapy treatment planning system.
William Hyatt, vice president and general manager of Varian's Brachytherapy business, said the single-channel system is "specifically engineered for these single catheter treatments and is designed to reduce the capital cost barriers often faced by hospitals wishing to offer the new accelerated breast brachytherapy techniques."